Bombay High Court Reverses Seizure of Bulk Commercial Ketamine Reserves

The Bombay High Court issued a ruling directing regulatory authorities to release a bulk consignment of pharmaceutical-grade ketamine valued at seventy-two lakh rupees back to its manufacturer. The decision overrides executive seizure mandates that had effectively stalled legal chemical manufacturing schedules for months. This judicial intervention exposes deep operational tension between narcotics enforcement agencies and legitimate pharmaceutical supply chains. Overzealous administrative seizures without rigorous evidentiary support continue to disrupt commercial operations, creating regulatory uncertainty for domestic chemical exporters. The immediate outcome enables the impacted pharmaceutical enterprise to resume contract manufacturing, while signaling to law enforcement agencies that administrative overreach will incur judicial rebukes. Future commercial seizures will face far higher evidentiary thresholds in regional courts.